4-Arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1)

被引:14
作者
Lim, Chae Jo [1 ,2 ]
Kim, Soo Hee [1 ,2 ]
Lee, Byung Ho [1 ]
Oh, Kwang-Seok [1 ]
Yi, Kyu Yang [1 ,2 ]
机构
[1] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305600, South Korea
[2] Univ Sci & Technol, Dept Med & Pharmaceut Chem, Taejon 305350, South Korea
关键词
Melanin concentrating hormone (MCH); MCH-R1; antagonists; 4-Arylphthalazin-1(2H)-one; Obesity; OBESITY; MICE;
D O I
10.1016/j.bmcl.2011.10.111
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 4-arylphthalazin-1(2H)-one linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of an extensive SAR study probing the effects of substituents on the 4-arylphthalazin-1(2H)-one C-4 aryl group led to the identification of the 4-(3,4-difluorophenyl) derivative as a highly potent MCH-R1 inhibitor with an IC50 = 1 nM. However, further investigations showed that this substance has unacceptable pharmacokinetic properties including a high clearance and volume of distribution. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:427 / 430
页数:4
相关论文
共 22 条
[1]   Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 [J].
Chambers, J ;
Ames, RS ;
Bergsma, D ;
Muir, A ;
Fitzgerald, LR ;
Hervieu, G ;
Dytko, GM ;
Foley, JJ ;
Martin, J ;
Liu, WS ;
Park, J ;
Ellis, C ;
Ganguly, S ;
Konchar, S ;
Cluderay, J ;
Leslie, R ;
Wilson, S ;
Sarau, HM .
NATURE, 1999, 400 (6741) :261-265
[2]   Chronic intracerebroventricular infusion of MCH causes obesity in mice [J].
Gomori, A ;
Ishihara, A ;
Ito, M ;
Mashiko, S ;
Matsushita, H ;
Yumoto, M ;
Ito, M ;
Tanaka, T ;
Tokita, S ;
Moriya, M ;
Iwaasa, H ;
Kanatani, A .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (03) :E583-E588
[3]   Enantioselective synthesis of SNAP-7941: Chiral dihydropyrimidone inhibitor of MCH1-R [J].
Goss, Jennifer M. ;
Schaus, Scott E. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (19) :7651-7656
[4]   Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances [J].
Hervieu, GJ .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (02) :211-229
[5]   Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC-4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists [J].
Jeon, Moon-Kook ;
Cheon, Hyae Gyeong .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (06) :504-538
[6]   Obesity as a medical problem [J].
Kopelman, PG .
NATURE, 2000, 404 (6778) :635-643
[7]  
Lee Sunghou, 2006, Journal of Pharmacological and Toxicological Methods, V53, P242, DOI 10.1016/j.vascn.2005.09.001
[8]   Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists [J].
Lim, Chae Jo ;
Kim, Nakjeong ;
Lee, Eun Kyoung ;
Lee, Byung Ho ;
Oh, Kwang-Seok ;
Yoo, Sung-eun ;
Yi, Kyu Yang .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) :2309-2312
[9]   Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance [J].
Ludwig, DS ;
Tritos, NA ;
Mastaitis, JW ;
Kulkarni, R ;
Kokkotou, E ;
Elmquist, J ;
Lowell, B ;
Flier, JS ;
Maratos-Flier, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :379-386
[10]  
McBriar MD, 2006, CURR OPIN DRUG DISC, V9, P496